SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

PDMR Share Transfer

9 Feb 2021 07:00

RNS Number : 3832O
Cerillion PLC
09 February 2021
Β 

AIM: CER

Cerillion plc

("Cerillion" or "the Company")

Β 

Director/PDMR shareholding

Β 

Cerillion plc, the billing, charging and customer relationship management software solutions provider,Β announces that it has been notified that on 5 February 2021, Mr Andrew Smith, Marketing Director, transferred 20,000 ordinary shares of GBP 0.005 each in the capital of the Company ("Ordinary Shares") to his spouse, Mrs Katherine Smith, for nil consideration (the "Transfer"). Following the Transfer, Mr Andrew Smith, together with his spouse, remains interested in a total of 34,540 Ordinary Shares, representing 0.12% of the Company's issued share capital.

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on exercise of Options and Transfer.

Β For further information please contact:

Β Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Oliver Gilchrist, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Euan Brown, William Hall

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Dan Mahoney

Β 

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has over 90 customer installations across over 40 countries.

Headquartered in London, Cerillion also has operations in Pune, India, where its Global Solutions Centre is located, Miami and Sydney.

Β 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Andrew Smith

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Marketing Director

b)

Β 

Initial notification /Amendment

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Cerillion PLC

b)

Β 

LEI

213800ISIZMUC3P46850

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conductedΒ Β 

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Β Ordinary shares of GBP 0.005 each

Β 

GB00BYYX6C66

b)

Β 

Nature of the transaction

Β 

Β Transfer for nil consideration

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β Β Price(s)

Β 

Volume(s)

Nil

20,000

Β 

d)

Β 

Aggregated information

Β - Aggregated volume

Β - Price

Not Applicable - Single Transaction

Β 

e)

Β 

Date of the transaction

Β 5 February 2021

f)

Β 

Place of the transaction

Β 

Outside a trading venue

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Katherine Smith

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

PCA of Andrew Smith, Marketing Director

b)

Β 

Initial notification /Amendment

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Cerillion PLC

b)

Β 

LEI

213800ISIZMUC3P46850

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conductedΒ Β 

a)

Β 

Description of the financial instrument, type of instrument

Identification code

Β 

Ordinary shares of GBP 0.005 each

GB00BYYX6C66

b)

Β 

Nature of the transaction

Β 

Receipt of transfer for nil consideration

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β Price(s)

Β 

Volume(s)

Nil

20,000

d)

Β 

Aggregated information

- Aggregated volume

- Price

Not Applicable - Single Transaction

e)

Β 

Date of the transaction

Β 5 February 2021

f)

Β 

Place of the transaction

Β 

Outside a trading venue

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSSEFUAEFSELE
Date   Source Headline
8th Jun 20265:50 pmRNSPDMR Dealing
1st Jun 20267:00 amRNSInterim Results
19th May 20267:00 amRNSInterim Results Investor Presentation
24th Apr 20262:46 pmRNSTR-1 Notification
22nd Apr 20267:00 amRNSH1 Trading Update
17th Apr 20268:00 amRNSExcercise of Options, Total Voting Rights
14th Apr 20267:00 amRNSCFO Joining Date and Date of Trading Update
9th Apr 202611:43 amRNSTR-1 Notification
27th Mar 20267:00 amRNSTR-1 Notification
26th Mar 20267:00 amRNS-RAchieves "Diamond-level" Open API Certification
5th Mar 202611:44 amRNSGrant of Options
19th Feb 20263:38 pmRNSResult of AGM
18th Feb 20267:00 amRNSNotification of Major Interest in Cerillion
13th Feb 202610:24 amRNSExercise of Options, Total Voting Rights
6th Feb 202610:37 amRNSExercise of Options, TVR, Block Admission Return
2nd Feb 202612:45 pmRNSExercise of Options and Total Voting Rights
28th Jan 20267:00 amRNSBoard Change - CFO Transition
14th Jan 20266:15 pmRNSExcercise of Options and Share Purchase
12th Jan 20269:15 amRNSPosting of Report and Accounts & Notice of AGM
8th Jan 20267:00 amRNSMajor Contract Win
2nd Dec 20255:19 pmRNSTR-1 Notification
24th Nov 20255:56 pmRNSExcercise of Options, PDMR Dealing
24th Nov 20257:00 amRNSFinal Results
3rd Nov 20257:00 amRNSNotice of Final Results
29th Oct 20257:00 amRNS-RLaunch of Cerillion 25.2
23rd Oct 20258:01 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFull Year Trading Update
25th Sep 20257:00 amRNS-RNamed in IDC MarketScape 2025 Assessment
8th Sep 20257:00 amRNSMajor follow-on contracts worth £17.3m
2nd Sep 20257:00 amRNS-RCerillion Recognised in two Gartner Reports
30th Jul 20257:00 amRNSExercise of Options, PDMR dealing and TVR
2nd Jul 20251:14 pmRNSEmployee Share Option Scheme and PDMR dealing
16th Jun 20257:00 amRNSTR-1 Notification
13th Jun 20257:47 amRNSPDMR shareholding - replacement
12th Jun 20251:50 pmRNSResult of Secondary Share Sale
11th Jun 20254:54 pmRNSProposed Secondary Placing
10th Jun 20256:30 pmRNSPDMR Shareholding
5th Jun 20257:37 amRNSDirector/PDMR Shareholding
19th May 20257:00 amRNSInterim Results
16th May 20251:29 pmRNSResult of General Meeting
12th May 20257:00 amRNSNotice of Results and Investor Presentation
30th Apr 20259:06 amRNSNotice of General Meeting
29th Apr 20253:51 pmRNSTR-1 Notification
14th Apr 20257:00 amRNSHalf-year Trading Update
17th Mar 20257:00 amRNSShare Purchase
13th Feb 20254:25 pmRNSResult of AGM
24th Jan 20259:51 amRNSPDMR Shareholding
22nd Jan 20259:35 amRNSPDMR Shareholding
20th Jan 20257:00 amRNSMajor New Contract
15th Jan 20257:00 amRNSShare purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.